pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Immunology · news · pharmadog
← back to Immunology
News · Immunology
996
stories
Aug 26, 26
Spyre’s rheumatoid arthritis plan toppled by subpar TL1A data
fiercebiotech
Aug 25, 26
J&J’s Imaavy wins label expansion; Two approvals in Japan
endpoints
Aug 25, 26
China’s Haisco forms immunology biotech with up to $1.5B from American VCs
biospace
Aug 25, 26
STAT+: Pharmalittle: We’re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more
stat
Aug 25, 26
Bausch + Lomb advances dry eye disease drug to Phase 3 despite mid-stage fail
biospace
Aug 25, 26
Founded by Metsera backers, Sentivera emerges with $1.5B inflammatory disease deal
fiercebiotech
Aug 25, 26
FDA drafts guidance on assessing potency of immunotherapy products
raps
Aug 24, 26
Boehringer Ingelheim suspends early study for pill candidate after ‘safety event’
biospace
Aug 22, 26
Third death in China’s expedited trials; Merck and Moderna’s cancer vaccine win; and more
endpoints
Aug 22, 26
Everything Sprouts, LLC Recalls Alfalfa Sprouts Due to Potential E. Coli and Salmonella Risk
fda recalls
Aug 21, 26
Lawmakers urge FDA to enact new China policies after 3 gene therapy trial deaths
biospace
Aug 21, 26
Werewolf and Ambros to tie the knot in $150M rare disease deal
biospace
Aug 20, 26
Cancer vaccine win restores Wall Street’s faith in Moderna
biopharma dive
Aug 20, 26
Boehringer places phase 1 study of investigational drug on hold to examine ‘safety event’
fiercebiotech
Aug 20, 26
Chutes & Ladders—Neumora shuffles leadership ahead of IND
fiercebiotech
Aug 20, 26
Lilly partners with Amplitude on vaccines; Otsuka scraps psychedelic trial
endpoints
Aug 20, 26
STAT+: One of the most consequential years for cancer treatment, ever
stat
Aug 20, 26
Why Pheast’s CEO has no regrets about transparent approach to R&D despite competitors circling
fiercebiotech
Aug 20, 26
Why pediatric rare oncology outperforms in a volatile biotech market
biospace
Aug 19, 26
B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter
fda recalls
Aug 19, 26
Amgen abandoning $500M+ Crohn’s collab won’t derail TScan’s pipeline strategy
fiercebiotech
Aug 19, 26
Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels
fda recalls
Aug 19, 26
Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma
biopharma dive
Aug 19, 26
Tolerance Bio jumps into phase 2 with $260M deal for thymus-targeting fusion protein
fiercebiotech
Aug 19, 26
She grew up unvaccinated. Now she’s a leading voice for science — and empathy
stat
Aug 18, 26
Merck, Moderna’s personalized cancer vaccine slows recurrence in phase 3, setting up approval push
fiercebiotech
Aug 18, 26
Exclusive: Third death revealed in China's popular but opaque trials
endpoints
Aug 18, 26
Regeneron ends eye disease study due to antibody's safety profile
biospace
Aug 18, 26
Regeneron ends eye disease study due to antibody's safety profile
biospace
Aug 17, 26
Argenx jumps on Phase 3 data for blockbuster Vyvgart
biopharma dive
← prev
page 20 of 34
next →